Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 1,427 shares at $29.34 ($42K) on 2025-12-02, disclosed to the SEC on 2025-12-04.
Open-market sale of $42k BBNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BBNX | SELL | 2026-06-03 | $84K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |